Showing results (2071-2080 of 13,891) with videos related to

Sort By:
Pageof 1,390
Indian Journal of Nephrology|December 26, 2022
Nell1 as Target Antigen for Mercury Related Membranous Nephropathy: A Case ReportNabadwip Pathak, Indra Gunasekaran, Moses Ambriose, et al.
Environmental Science and Pollution Research International|June 1, 2022
3-Indolepropionic acid prevented chlorpyrifos-induced hepatorenal toxicities in rats by improving anti-inflammatory, antioxidant, and pro-apoptotic responses and abating DNA damageSolomon E Owumi, Eseroghene S Najophe, Moses T Otunla
Microbiology Insights|July 5, 2022
Characteristics of Virulence Factors and Prevalence of Virulence Markers in Resistant Escherichia coli from Patients with Gut and Urinary Infections in Lafia, NigeriaOlukayode Olugbenga Orole, Salihu Moses Gambo, Victor Stephen Fadayomi
Journal of Peptide Science : an Official Publication of the European Peptide Society|July 5, 2022
Evaluation of unexpected protecting group removal in solid-phase peptide synthesis: Quantified using continuous flow methodsVictoire Laude, Manuel Nuño, Roger C Moses, et al.
The Pan African Medical Journal|June 20, 2022
COVID-19: knowledge, perception of risk, preparedness and vaccine acceptability among healthcare workers in KenyaHafso Mohamed Abdulle, Moses Muia Masika, Julius Otieno Oyugi
Expert Opinion on Pharmacotherapy|May 26, 2010
Current role of statins in the treatment of essential hypertensionMichael S Kostapanos, Haralampos J Milionis, Moses S Elisaf
Ciba Foundation Symposium|January 1, 1991
Regulation of epithelial proliferation by TGF-betaH L Moses, E Y Yang, J A Pietenpol
Plos One|August 15, 2014
Skills training of health workers in the use of a non surgical device (PrePex) for adult Safe Male CircumcisionMoses Galukande, Kevin Duffy, Jean Paul Bitega, et al.
MRS Bulletin|November 19, 2013
Wound Healing Versus Regeneration: Role of the Tissue Environment in Regenerative MedicineAnthony Atala, Darrell J Irvine, Marsha Moses, et al.
BMC Infectious Diseases|April 22, 2016
Mycobacterium tuberculosis Uganda II is more susceptible to rifampicin and isoniazid compared to Beijing and Delhi/CAS familiesGeorge W Kasule, David P Kateete, Moses L Joloba
Pageof 1,390